MIRM   $90.72  -1.03% Market Closed After Close 90.72 0.0

Mirum Pharmaceuticals, Inc.

EMA (20): 2026-02-26 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2026-02-26 the price crossed down the moving average line and formed a short-term downside trend.

EMA (100): 2025-12-16 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: down-crossing the middle level.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: signal line crossed the middle level.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -4.76%
EMA (20) date of signal Feb. 26, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -4.76%
EMA (50) date of signal Feb. 26, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 30.95%
EMA (100) date of signal Dec. 16, 2025, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -2.54%
RSI (14) date of signal March 2, 2026, 3 a.m.
MACD Signals bearish
MACD Yield 0.0
MACD date of signal March 3, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -2.54%
Stochastic date of signal March 2, 2026, 3 a.m.
Updated March 4, 2026, 8:39 p.m.